Department of Gynecology and Obstetrics, The Johns Hopkins University School of Medicine, Baltimore, MD (Drs Gaur and Uribe).
Division of Maternal-Fetal Medicine, Department of Gynecology and Obstetrics, The Johns Hopkins University School of Medicine, Baltimore, MD (Drs Darwin, Kohn, and Eke).
Am J Obstet Gynecol MFM. 2023 Sep;5(9):101057. doi: 10.1016/j.ajogmf.2023.101057. Epub 2023 Jun 15.
Despite findings that maternal COVID-19 infection in pregnancy is associated with low birthweight (weight of ≤2500 g), previous studies demonstrate no difference in low birthweight risk between COVID-19 vaccinated and unvaccinated pregnant persons. Few studies, however, have examined the association between unvaccinated, incomplete vaccination, and complete vaccination on low birthweight, and they have been limited by small sample sizes and lack of adjustment for covariates.
We sought to address key limitations of prior work and evaluate this association between unvaccinated, incomplete, and complete COVID-19 vaccination status in pregnancy and low birthweight. We predicted a protective association of vaccination on low birthweight that varies by number of doses received.
We performed a population-based retrospective study using the Vizient clinical database, which included data from 192 hospitals in the United States. Our sample included pregnant persons who delivered between January 2021 and April 2022 at hospitals that reported maternal vaccination data and birthweight at delivery. Pregnant persons were categorized into 3 groups as follows: unvaccinated; incompletely vaccinated (1 dose of Pfizer or Moderna); or completely vaccinated (1 dose of Johnson & Johnson or ≥2 doses of Moderna or Pfizer). Demographics and outcomes were analyzed using standard statistical tests. We performed multivariable logistic regression to account for potential confounders between vaccination status and low birthweight in the original cohort. Propensity score matching was used to reduce bias related to the likelihood of vaccination, and the multivariable logistic regression model was then applied to the propensity score-matched cohort. Stratification analysis was performed for gestational age and race and ethnicity.
Of the 377,995 participants, 31,155 (8.2%) had low birthweight, and these participants were more likely to be unvaccinated than those without low birthweight (98.8% vs 98.5%, P<.001). Incompletely vaccinated pregnant persons were 13% less likely to have low birthweight neonates compared to unvaccinated persons (odds ratio, 0.87; 95% confidence interval, 0.73-1.04), and completely vaccinated persons were 21% less likely to have low birthweight neonates (odds ratio, 0.79; 95% confidence interval, 0.79-0.89). After controlling for maternal age, race or ethnicity, hypertension, pregestational diabetes, lupus, tobacco use, multifetal gestation, obesity, use of assisted reproductive technology, and maternal or neonatal COVID-19 infections in the original cohort, these associations remained significant for only complete vaccination (adjusted odds ratio, 0.80; 95% confidence interval, 0.70-0.91) and not incomplete vaccination (adjusted odds ratio, 0.87; 95% confidence interval, 0.71-1.04). In the propensity score-matched cohort, pregnant persons who were completely vaccinated against COVID-19 were 22% less likely to have low birthweight neonates compared to unvaccinated and incompletely vaccinated individuals (adjusted odds ratio, 0.78; 95% confidence interval, 0.76-0.79).
Pregnant persons who were completely vaccinated against COVID-19 were less likely to have low birthweight neonates compared to unvaccinated and incompletely vaccinated individuals. This novel association was observed among a large population after adjusting for confounders of low birthweight and factors influencing the likelihood of receiving the COVID-19 vaccine.
尽管有研究表明,孕妇 COVID-19 感染与低出生体重(体重≤2500 克)有关,但之前的研究表明,COVID-19 疫苗接种和未接种孕妇的低出生体重风险没有差异。然而,很少有研究检查未接种、不完全接种和完全接种对低出生体重的影响,而且这些研究受到样本量小和缺乏调整协变量的限制。
我们旨在解决先前工作的关键局限性,并评估怀孕期间未接种、不完全和完全 COVID-19 疫苗接种状态与低出生体重之间的这种关联。我们预测接种疫苗对低出生体重有保护作用,且这种保护作用因接种剂量而异。
我们使用 Vizient 临床数据库进行了一项基于人群的回顾性研究,该数据库包含来自美国 192 家医院的数据。我们的样本包括 2021 年 1 月至 2022 年 4 月在报告产妇疫苗接种数据和分娩时出生体重的医院分娩的孕妇。将孕妇分为以下 3 组:未接种;不完全接种(1 剂辉瑞或 Moderna);或完全接种(1 剂强生或≥2 剂 Moderna 或辉瑞)。使用标准统计检验分析人口统计学和结局。我们进行了多变量逻辑回归,以解释原始队列中疫苗接种状态和低出生体重之间的潜在混杂因素。采用倾向评分匹配来减少与接种可能性相关的偏差,并将多变量逻辑回归模型应用于倾向评分匹配队列。对妊娠年龄和种族和民族进行分层分析。
在 377995 名参与者中,31155 人(8.2%)有低出生体重,与无低出生体重者相比,这些参与者更有可能未接种疫苗(98.8%比 98.5%,P<.001)。与未接种疫苗者相比,不完全接种疫苗的孕妇低出生体重儿的可能性降低了 13%(优势比,0.87;95%置信区间,0.73-1.04),而完全接种疫苗的孕妇低出生体重儿的可能性降低了 21%(优势比,0.79;95%置信区间,0.79-0.89)。在控制了母亲年龄、种族或民族、高血压、孕前糖尿病、狼疮、吸烟、多胎妊娠、肥胖、辅助生殖技术的使用以及产妇或新生儿 COVID-19 感染后,这些关联在原始队列中仅对完全接种疫苗仍然具有统计学意义(调整后的优势比,0.80;95%置信区间,0.70-0.91),而不完全接种疫苗则没有统计学意义(调整后的优势比,0.87;95%置信区间,0.71-1.04)。在倾向评分匹配队列中,与未接种和不完全接种疫苗的个体相比,完全接种 COVID-19 疫苗的孕妇低出生体重儿的可能性降低了 22%(调整后的优势比,0.78;95%置信区间,0.76-0.79)。
与未接种和不完全接种疫苗的个体相比,完全接种 COVID-19 疫苗的孕妇低出生体重儿的可能性降低。在调整了低出生体重的混杂因素和影响 COVID-19 疫苗接种可能性的因素后,在大量人群中观察到了这种新的关联。